EC
SGHT icon

EntryPoint Capital’s Sight Sciences SGHT Stock Holding History

EntryPoint Capital’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,256
Closed -$70.9K – 939
2024
Q3 		$70.9K Buy
11,256
+6,053
+116% +$40.7K 0.04% 571
2024
Q2 		$34.7K Buy
+5,203
New +$30.8K 0.05% 633

Other funds holding SGHT

JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

EntryPoint Capital's SGHT Position: Q4 2024 in Review

EntryPoint Capital sold out of Sight Sciences (SGHT) in Q4 2024, closing a stake of 11,256 shares — an estimated $70.9K sold.

EntryPoint Capital first reported a position in SGHT in Q2 2024 and held it in 2 quarters. The position peaked at $70.9K in Q3 2024. 83 funds tracked by Wall St. Rank hold SGHT as of Q4 2024.

  • EntryPoint Capital reported no remaining Sight Sciences position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 11,256 Sight Sciences shares in Q4 2024, an estimated $70.9K.
  • EntryPoint Capital first reported a position in Sight Sciences in Q2 2024 and held it in 2 quarters.
  • EntryPoint Capital's Sight Sciences position peaked at $70.9K in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.